European Bioanalysis Forum: recommendation for dealing with internal standard variability

Author:

White Stephen1,Adcock Neil2,Elbast Walid3,Hiller Jim4,Knutsson Magnus5,Lausecker Berthold6,Long Jeff7,McDougall Stuart8,Salavert Fabrice9,Sangster Timothy10,Verhaeghe Tom11,Amsterdam Peter van12

Affiliation:

1. Bioanalytical Science & Toxicokinetics, Drug Metabolism & Pharmacokinetics, GlaxoSmithKline R&D, Ware, UK

2. LGC, UK

3. Novartis, Switzerland

4. HOLOGIC Ltd., UK

5. Ferring, Denmark

6. CRS, Germany

7. Formerly of Shire, UK

8. Covance, UK

9. Actelion, Switzerland

10. Charles River Laboratories, UK

11. Janssen R&D, Belgium

12. Abbott Healthcare Products, The Netherlands

Abstract

Adequate monitoring of internal standard (IS) response across an analytical run and identification of anomalies is now a common expectation. However, the means to conduct this assessment in an appropriate manner is unclear and differs widely between laboratories. A European Bioanalysis Forum (EBF) topic team was formed to survey current practices within European Bioanalysis Forum member companies and to recommend a best practice approach for dealing with IS response variability.

Publisher

Future Science Ltd

Subject

Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3